163 related articles for article (PubMed ID: 23478972)
1. Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).
Gargala G; François A; Favennec L; Rossignol JF
Antimicrob Agents Chemother; 2013 Jun; 57(6):2821-3. PubMed ID: 23478972
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
Baishanbo A; Gargala G; Duclos C; François A; Rossignol JF; Ballet JJ; Favennec L
J Antimicrob Chemother; 2006 Feb; 57(2):353-5. PubMed ID: 16361328
[TBL] [Abstract][Full Text] [Related]
3. Systemic efficacy on
Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
5. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
Schnyder M; Kohler L; Hemphill A; Deplazes P
Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
[TBL] [Abstract][Full Text] [Related]
6. Nitazoxanide.
Parashar A; Arya R
Indian Pediatr; 2005 Nov; 42(11):1161-5. PubMed ID: 16340060
[No Abstract] [Full Text] [Related]
7. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
9. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.
Baishanbo A; Gargala G; Delaunay A; François A; Ballet JJ; Favennec L
Infect Immun; 2005 Aug; 73(8):5252-5. PubMed ID: 16041051
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.
Viel H; Rocques H; Martin J; Chartier C
Parasitol Res; 2007 Dec; 102(1):163-6. PubMed ID: 17874133
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
[TBL] [Abstract][Full Text] [Related]
12. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
[TBL] [Abstract][Full Text] [Related]
14. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.
Gargala G; Baishanbo A; Favennec L; François A; Ballet JJ; Rossignol JF
Antimicrob Agents Chemother; 2005 Nov; 49(11):4628-34. PubMed ID: 16251305
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
Li X; Brasseur P; Agnamey P; Leméteil D; Favennec L; Ballet JJ; Rossignol JF
Folia Parasitol (Praha); 2003 Mar; 50(1):19-22. PubMed ID: 12735719
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
[TBL] [Abstract][Full Text] [Related]
20. Intestinal cryptosporidiosis in a 2-month-old child.
Sanghai SR; Shah I
Natl Med J India; 2012; 25(2):122. PubMed ID: 22686724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
